Page last updated: 2024-11-12

pentolame

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pentolame: 17-beta-amino-estrogen with anticoagulant & estrogenic effects; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10473548
MeSH IDM0221477

Synonyms (4)

Synonym
150748-24-6
pentolame
(8r,9s,13s,14s,17s)-17-(5-hydroxypentylamino)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-ol
DTXSID801188752

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dose-response curves were performed using immature CD1 mice and Wistar rats."( Estrogenic effects of 17 beta-aminoestrogens assessed in uteri of rats and mice.
Avila, ME; Franco, Y; Jaimez, R; Lemini, C, 2005
)
0.33
" Dose-response curves were performed in rats by single subcutaneous (s."( Effects of 17beta-aminoestrogens on the sexual behavior of female rats.
Canchola, E; Lemini, C, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (5.88)18.2507
2000's11 (64.71)29.6817
2010's4 (23.53)24.3611
2020's1 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.36 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.98 (4.65)
Search Engine Demand Index53.49 (26.88)
Search Engine Supply Index4.00 (0.95)

This Compound (25.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]